Obiettivo
A revolution in breast cancer care is likely as we move from empirical towards molecular oncology. For Europe to lead this revolution, the Breast International Group is planning a "sister" network of excellence -TRANS-BIG- dedicated to multinational translational research linked to prospective clinical trials. At the heart of TRANS-BIG is a large, non drug-oriented, molecular-based adjuvant trial for node negative patients, preceded by a validation/standardisation phase linking the genomic analysis of frozen tumour specimens to patient outcome. These exploratory and clinical studies intend, through DNA microarray gene expression, to identify patient subgroups that could be spared toxic/expensive adjuvant treatment. Such treatment tailoring for the highest incidence cancer in women might significantly decrease its economic burden. This trial aims to prospectively validate the 70-gene poor prognosis signature identified by Dutch researchers as a potentially better discriminator of outcome than traditional clinical/pathological factors. Additionally, traditional pathology analysis and bioinformatics/statistics will be centralised, contributing to standardisation/integration within the network. In light of rapidly evolving technologies, TRANS-BIG will ensure appropriate collection and storage of patient tumour/blood samples, allowing for future analysis such as proteomics and the development of user-friendly and commercially available tools in collaboration with several European SMEs. With a dedicated Ethical-Legal Committee TRANS-BIG will comply with all national/international regulations governing such research. Spreading of excellence will be achieved in partnership with Europa Donna and FECS, the latter coordinating a traineeship programme to provide opportunities for European researchers to acquire skills in breast cancer research/associated technologies.
Campo scientifico
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- natural sciencesbiological sciencesgeneticsDNA
- social sciencespolitical sciencespolitical transitionsrevolutions
- medical and health sciencesclinical medicineoncologybreast cancer
- medical and health sciencesbasic medicinepathology
Parole chiave
Invito a presentare proposte
FP6-2002-LIFESCIHEALTH
Vedi altri progetti per questo bando
Meccanismo di finanziamento
NoE - Network of ExcellenceCoordinatore
BRUSSELS
Belgio
Mostra sulla mappa
Partecipanti (43)
AMSTERDAM
Mostra sulla mappa
COPENHAGEN
Mostra sulla mappa
VIENNA
Mostra sulla mappa
BRUSSELS
Mostra sulla mappa
BRUSSELS
Mostra sulla mappa
BARCELONA
Mostra sulla mappa
MADRID
Mostra sulla mappa
SANTIAGO
Mostra sulla mappa
NEUHERBERG
Mostra sulla mappa
LONDON
Mostra sulla mappa
VILLEJUIF
Mostra sulla mappa
MENDRISIO (TICINO)
Mostra sulla mappa
PORTO
Mostra sulla mappa
FRANKFURT / MAIN
Mostra sulla mappa
616 MAASTRICHT
Mostra sulla mappa
ISTANBUL
Mostra sulla mappa
HALLE
Mostra sulla mappa
MOSCOW
Mostra sulla mappa
ATHENS
Mostra sulla mappa
PORTO
Mostra sulla mappa
OXFORD
Mostra sulla mappa
EDINBURGH
Mostra sulla mappa
KÖLN
Mostra sulla mappa
DUESSELDORF
Mostra sulla mappa